Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
Ramón Lecumberri,
Laura Jiménez,
Pedro Ruiz-Artacho,
José Antonio Nieto,
Nuria Ruiz-Giménez,
Adriana Visonà,
Andris Skride,
Fares Moustafa,
Javier Trujillo,
Manuel Monreal
Affiliations
Ramón Lecumberri
Hematology Service, Clínica Universidad de Navarra, IdISNA, Pamplona; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain
Laura Jiménez
Deparment of Internal Medicine, Hospital Virgen de la Luz, Cuenca, Spain
Pedro Ruiz-Artacho
Deparment of Internal Medicine, Interdisciplinar Teragnosis and Radiosomics Research Group (INTRA-Madrid), Instituto de Salud Carlos III, University of Navarra, Clínica Universidad de Navarra, CIBERES, Madrid, Spain
José Antonio Nieto
Deparment of Internal Medicine, Hospital Virgen de la Luz, Cuenca, Spain
Nuria Ruiz-Giménez
Department of Internal Medicine, Hospital Universitario de La Princesa, Madrid, Spain
Adriana Visonà
Department of Vascular Medicine, Ospedale Castelfranco Veneto, Castelfranco Veneto, Italy
Andris Skride
Department of Cardiology, Ospedale Pauls Stradins Clinical University Hospital, Riga Stradiņš University, Riga, Latvia
Fares Moustafa
Department of Emergency, Clermont-Ferrand University Hospital, Clermont-Ferrand, France
Javier Trujillo
Department of Internal Medicine, Hospital General Universitario Santa Lucía, Universidad Católica de Murcia, Murcia, Spain
Manuel Monreal
Department of Internal Medicine, Instituto de Salud Carlos III, Universidad Católica de Murcia, Hospital Germans Trias i Pujol, CIBERES, Badalona (Barcelona), Madrid, Spain
The performance of validated bleeding risk scores in patients with venous thromboembolism (VTE) could be different depending on the time after index event or the site of bleeding. In this study we compared the “classic” Registro Informatizado de Enfermedad TromboEmbólica (RIETE) score and the more recently developed VTE-BLEED score for the prediction of major bleeding in patients under anticoagulant therapy in different time intervals after VTE diagnosis. Out of 82,239 patients with acute VTE, the proportion of high-risk patients according to the RIETE and VTE-BLEED scores was 7.1 and 62.3%, respectively. The performance of both scores across the different study periods (first 30 days after VTE diagnosis, days 31–90, days 91–180, and days 181–360) was similar, with areas under the receiving operating characteristics (ROC) curve (AUC) ranging between 0.69 and 0.72. However, the positive predictive values were low, ranging between 0.6 and 3.9 (better for early major bleeding than for later periods). A sensitivity analysis limited to patients with unprovoked VTE showed comparable results. Both scores showed a trend toward a better prediction of extracranial than intracranial major bleeding, the RIETE score resulting more useful for early extracranial bleeding and the VTE-BLEED for late intracranial hemorrhages. Our study reveals that the usefulness of available bleeding scores may vary depending on the characteristics of the patient population and the time frame evaluated. Dynamic scores could be more useful for this purpose.